Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report
- PMID: 23516009
- PMCID: PMC3598305
- DOI: 10.4314/ahs.v12i4.30
Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report
Abstract
Amlodipine is a dihydropyridine calcium channel blocker that is used in the management of both hypertension and angina. Amlodipine induced side effects are headache, dizziness, edema, flushing, palpitations, and rarely gingival hyperplasia. The exact reason of amlodipine-induced gingival hyperplasia is not known. We presented a case with chronic renal failure (CRF) that developed gingival hyperplasia due to amlodipine use, which improved after ceasing the drug.
Keywords: Amlodipine; chronic renal failure; gingival hyperplasia.
Figures
References
-
- Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J. 1989 Nov;118(5 Pt 2):1100–1103. - PubMed
-
- Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR. Gingival sequestration of amlodipine induced gingival overgrowth. Lancet. 1993;341:1102–1103. - PubMed
-
- Jorgensen MG. Prevalence of amlodipine related gingival hyperplasia. J Periodontol. 1997;68:678. - PubMed
-
- Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival over-growth induced by calcium channel blockers: a community-based study. J Periodontol. 1997;0:63–67. - PubMed
-
- Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol. 1992 May;63(5):453–456. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical